Ultrasound Guided Axillary Venous Cannulation in Pediatrics

Real-time Ultrasound-guided Axillary Venous Catheterization in Pediatric Patients: Comparison With the Landmark Technique Subclavian Vein Catheterization

Status

Completed

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT02806401

Enrollment

132

Registered

2016-06-20

Start date

2016-06-30

Completion date

2017-08-31

Last updated

2018-09-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ultrasound Guided Central Venous Cannulation

Brief summary

The purpose of this prospective randomized study was to compare landmark-subclavian venous access to ultrasound-guided axillary venous access when performed by pediatric anesthesiologists.

Detailed description

Objective: Subclavian vein catheterization may cause various complications. The investigators will compare the real-time ultrasound-guided axillary venous access vs. the landmark method- subclavian venous access in pediatric paticipants. (the needle insertion point of ultrasound-guided axillary venous is axillary vein. and the needle insertion point of landmark method is infraclavicular subclavian vein) Design: Prospective randomized study. Setting: Operating room of a tertiary medical center. Interventions: The investigators will compare the ultrasound-guided axillary vein cannulation (66 paticipants) vs. the landmark method (66 pa- ticipants).

Interventions

DEVICElandmark

DEVICEUS_Ax

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

HEALTH_SERVICES_RESEARCH

Masking

SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender

ALL

Age

1 Months to 7 Years

Healthy volunteers

Inclusion criteria

* surgery under general anesthesia require central venous catheterization

Exclusion criteria

* hematoma in central vein central vein anomaly catheterization site infection

Design outcomes

Primary

Measure	Time frame
2nd access success rate	interval between skin penetration and removal of the needle or catheter after central line insertion, an expected average of 120 seconds

Secondary

Measure	Time frame
1st access success rate	interval between skin penetration and removal of the needle or catheter after central line insertion, an expected average of 120 seconds
3rd access success rate	interval between skin penetration and removal of the needle or catheter after central line insertion, an expected average of 120 seconds
total time	interval between skin penetration and removal of the needle or catheter after central line insertion, an expected average of 120 seconds

Countries

South Korea

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026